Assisted Reproductive Technology through Artificial Intelligence

By Sumona Bose

March 6, 2024

Introduction

Since the first successful in vitro fertilisation (IVF) birth in 1978, assisted reproductive technology (ART) has advanced, aiding over eight million infertile couples in conceiving. The intricate protocols of IVF involve critical decision-making points handled by clinicians and embryologists, blending evidence-based choices with subjective judgments, shaping ART as both science and art. Artificial intelligence (AI) offers a promising avenue for optimising ART processes like drug selection, cycle monitoring, and embryo selection. Could this be a beginning to a future of unbelievable progress in the field of reproductive health?

Personalising ART with Machine Learning

Customising ART based on individual factors like ovarian reserve, genetic variations, and ethnic disparities can significantly impact treatment success. Machine learning (ML) methods enable tailoring treatment regimens to patient subgroups, optimising ovarian response, and luteal phase support. The integration of ML algorithms into clinical decision support systems (CDSS) harnesses the potential of electronic health records, offering personalised and data-driven approaches to enhance ART outcomes. As shown in Figure 1, the procedures involving ART are intricate, demanding thorough supervision. Clinicians and embryologists bear the responsibility for numerous crucial decision junctures both before and throughout the treatment cycle. AI contributes to this complex process with its data analysis skills.

Figure 1: Potential targets for the application of artificial intelligence and ML methods during clinical and embryological steps in ART. The order and timings of the steps can differ depending on the ART protocol used.

Transparency and Trust in AI Applications

The adoption of AI in ART faces challenges related to trust and interpretability, especially with complex ‘black-box’ models. Transparency emerges as a crucial factor in AI systems to ensure clinicians’ confidence in decision-making tools. Efforts to enhance explainability in AI models, particularly in image-based analyses in embryology, aim to provide insights into model reliability, fairness, and trustworthiness, paving the way for more widespread and effective use of AI in reproductive healthcare.

Conclusion

The integration of AI technologies holds immense promise in ART, offering personalised, data-driven, and transparent solutions to enhance the success rates and safety of assisted reproduction procedures. The blend of science and art in ART, with its intricate protocols and subjective decision-making, sets the stage for AI to make significant advancements in this field.

Reference url

Recent Posts

Dementia Pharmacotherapy Guidelines: Emphasizing Non-Pharmacological Approaches in Dutch Care

By João L. Carapinha

May 1, 2026

Dementia Pharmacotherapy Guidelines in the Netherlands continue to emphasize a primarily non-pharmacological approach to care. The revised Dutch pharmacotherapeutic consultation document highlights the modest clinical benefits of available drug treatments and assigns cholinesterase inhibitors (do...
Gaps in AI Governance Healthcare Frameworks: Ensuring Effective Implementation for Patient Safety
AI Governance Healthcare Frameworks remain fragmented and incomplete, limiting their practical value for healthcare organisations. A major scoping review has found that most existing frameworks lack the comprehensive structure needed for safe, real-world AI deployment in hospitals and acute care ...
Merck Q1 2026 Performance: Growth and Innovations in Oncology and Cardiometabolic Care

By HEOR Staff Writer

April 30, 2026

Merck’s first-quarter 2026 results have been published and highlight key growth drivers, regulatory achievements, and strategic moves that reinforce the company’s diversified portfolio. Oncology Dominance Fueled by KEYTRUDA Expansion Merck Q1 2026 performance was prima...